Concepedia

Xiangyu Wang

XW

21

Publications

1.5K

Citations

15

H-Index

2012

Active since

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Harvard University

Massachusetts General Hospital

Huazhong University of Science and Technology

Tongji Hospital

Xiangyu Wang is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2012–2023

21

Publications

21

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 689 citations · Full text

Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer

Xiangyi Kong, Yihang Qi, Xiangyu Wang et al. · Progress in Materials Science · 2023 · 134 citations

, , +10

Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator

Li Chen, Ping Bai, Xiangyi Kong et al. · Frontiers in Cell and Developmental Biology · 2021 · 118 citations · Full text

LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1

Bolun Ai, Xiangyi Kong, Xiangyu Wang et al. · Cell Death and Disease · 2019 · 74 citations · Full text

Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer

Qiang Liu, Jie Zhai, Xiangyi Kong et al. · Molecular Therapy — Oncolytics · 2020 · 61 citations · Full text

, , +16

Rows per page

1–5 of 21